• RBC Capital Adjusts Ascendis Pharma Price Target to $280 From $275, Maintains Outperform Rating marketscreener.com Tue, 07 Jul 2026 11:46:32 GMT
• Ascendis Pharma A/S (ASND) Stock Analysis: Strong Buy Ratings and Promising Revenue Growth Capture Investor Interest DirectorsTalk Interviews Mon, 06 Jul 2026 09:15:03 GMT
• (asnd) price dynamics and execution-aware positioning Stock Traders Daily Sun, 05 Jul 2026 22:34:01 GMT
• Ascendis Pharma (ASND) Could Be 7% Undervalued Following Fresh ApproaCH Trial Data simplywall.st Sat, 04 Jul 2026 00:19:22 GMT
• ascendis pharma (asnd) could be 7% undervalued following fresh approach trial data simplywall.st Fri, 03 Jul 2026 23:43:17 GMT
• ascendis pharma stock: behind the stock surge (nasdaq:asnd) Seeking Alpha Thu, 02 Jul 2026 13:44:33 GMT
• ascendis pharma added to russell 3000, russell 1000 and other us indexes MSN Thu, 02 Jul 2026 09:04:38 GMT
• Ascendis Pharma A/S Announces New Radiographic Data from Week 104 of the Completed Pivotal Approach Trial of Once-Weekly Transcon ... marketscreener.com Tue, 30 Jun 2026 14:21:35 GMT
• Ascendis Pharma A/S - Announces Week 104 Data From Approach Trial Of Transcon CNP In Children With Achondroplasia TradingView Tue, 30 Jun 2026 12:43:34 GMT
• Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of t... GlobeNewswire Tue, 30 Jun 2026 12:30:00 GMT
• ascendis drug data show leg alignment kept improving through 2 years Stock Titan Tue, 30 Jun 2026 12:30:00 GMT
• Ascendis Pharma (ASND) shares 2-year TransCon CNP ApproaCH achondroplasia results Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Ascendis Pharma A/S(NasdaqGS:ASND) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 21:02:53 GMT
• Ascendis Pharma A/S(NasdaqGS: ASND) added to Russell Midcap Value Benchmark marketscreener.com Mon, 29 Jun 2026 17:40:39 GMT
• Ascendis Pharma (ASND) adds 177,267 shares via warrant exercises Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $288 Moomoo Mon, 29 Jun 2026 07:00:00 GMT
• Ascendis Pharma A/S(NasdaqGS: ASND) added to Russell Midcap Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ascendis pharma a/s(nasdaqgs:asnd) added to russell small cap comp value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• ascendis pharma (asnd) moves 9.9% higher: will this strength last? MSN Sun, 28 Jun 2026 10:45:40 GMT
• ascendis pharma added to russell 3000, russell 1000 and other us indexes MSN Sun, 28 Jun 2026 05:37:40 GMT
• Ascendis Pharma added to Russell 1000 and other indexes By Investing.com Investing.com Nigeria Sat, 27 Jun 2026 05:04:21 GMT
• ascendis pharma added to russell 3000, russell 1000 and other us indexes MSN Sat, 27 Jun 2026 04:39:07 GMT
• ascendis pharma (asnd) joins russell indexes in 2026 reconstitution GuruFocus Fri, 26 Jun 2026 23:46:27 GMT
• ascendis pharma added to russell 3000, russell 1000 and other us indexes MSN Fri, 26 Jun 2026 21:04:08 GMT
• Ascendis Pharma added to Russell 1000 and other indexes By Investing.com Investing.com Canada Fri, 26 Jun 2026 20:11:29 GMT
• Ascendis Joins Multiple Russell U.S. Indexes, Including the GlobeNewswire Fri, 26 Jun 2026 20:01:00 GMT
• what does yuviwel's fda approval mean for ascendis pharma Kavout | AI Fri, 26 Jun 2026 15:33:17 GMT
• Ascendis Pharma (ASND) Moves 9.9% Higher: Will This Strength Last? Yahoo Finance Fri, 26 Jun 2026 07:00:00 GMT
• ascendis lands in four russell indexes as rebalancing takes effect Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• ascendis pharma reveals positive trial data for achondroplasia treatments at iccbh 2026. Pluang Fri, 26 Jun 2026 04:01:04 GMT
• ascendis to show 104-week achondroplasia data in montreal Stock Titan Thu, 25 Jun 2026 20:01:00 GMT
• beyond height: ascendis's dual-action therapy targets achondroplasia's deeper complexities BriefGlance Thu, 25 Jun 2026 20:01:00 GMT
• Ascendis Pharma jumps as investors weigh cash boost, pipeline momentum, and possible index-related buying Quiver Quantitative Thu, 25 Jun 2026 15:53:00 GMT
• ascendis pharma (asnd) could be 30% undervalued following mixed share price moves simplywall.st Thu, 25 Jun 2026 09:30:15 GMT
• Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026 Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• Ascendis Pharma reveals positive trial data for achondroplasia treatments at ICCBH 2026. Pluang Thu, 25 Jun 2026 07:00:00 GMT
• (asnd) as a liquidity pulse for institutional tactics Stock Traders Daily Wed, 24 Jun 2026 21:26:02 GMT
• final trades: ascendis pharma, monolithic power, the iyc and the gpiq corinthians x são paulo (wahz3amvr9) Mshale Wed, 24 Jun 2026 04:13:29 GMT
• J.P. Morgan Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• wells fargo maintains ascendis pharma a/s(asnd.us) with buy rating, maintains target price $326 富途牛牛 Thu, 18 Jun 2026 04:23:36 GMT
• ascendis pharma a/s (asnd) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 01:01:05 GMT
• Ascendis Pharma (NASDAQ: ASND) nets $187.5M from FDA PRV sale Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Wells Fargo Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $326 Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• bofa securities maintains ascendis pharma a/s(asnd.us) with buy rating, maintains target price $288 Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• ascendis pharma's yorvipath has superior profile relative to competitors, wedbush says marketscreener.com Mon, 15 Jun 2026 14:55:33 GMT
• ascendis pharma a/s (asnd) stock analysis: a biotech powerhouse with 36.97% potential upside DirectorsTalk Interviews Mon, 15 Jun 2026 09:15:40 GMT
• Ascendis Pharma A/S (ASND) Presents at Endocrine Society's Annual Meeting (ENDO 2026) - Slideshow Seeking Alpha Mon, 15 Jun 2026 07:00:00 GMT
• Oppenheimer reiterates Ascendis Pharma stock rating on drug data Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• wedbush maintains ascendis pharma a/s(asnd.us) with buy rating, maintains target price $273 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• long-term transcon pth data from ascendis pharma (asnd) show sustained benefits Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• ascendis pharma says transcon pth shows sustained efficacy at 5 years Moomoo Sat, 13 Jun 2026 14:28:56 GMT
• Ascendis Pharma Reports Sustained Efficacy and Safety of TransCon PTH in Phase 3 PaTHway Trial for Hypoparathyroidism After Three ... Quiver Quantitative Sat, 13 Jun 2026 07:00:00 GMT
• phase 3 data show transcon® pth replicated systemic actions GlobeNewswire Sat, 13 Jun 2026 07:00:00 GMT
• hormone shot helps hypoparathyroidism patients cut daily calcium and vitamin d Stock Titan Sat, 13 Jun 2026 07:00:00 GMT
• five-year transcon pth trial results reported by ascendis pharma (asnd) Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• why is ascendis pharma stock gaining friday? - ascendis pharma (nasdaq:asnd) Benzinga Fri, 12 Jun 2026 07:00:00 GMT
• ascendis pharma's transcon pth shows 5-year success in hypoparathyroidism treatment, boosting stock. Pluang Fri, 12 Jun 2026 07:00:00 GMT
• ascendis reports 5-year data for hypoparathyroidism drug Investing.com UK Fri, 12 Jun 2026 06:40:46 GMT
• ascendis pharma says transcon pth shows sustained efficacy at 5 years Moomoo Thu, 11 Jun 2026 20:35:55 GMT
• ascendis reports 5-year data for hypoparathyroidism drug Investing.com Thu, 11 Jun 2026 20:24:19 GMT
• 5-year trial: drug frees most hypoparathyroidism patients from supplements Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• 5-year phase 2 data show transcon® pth replicated systemic GlobeNewswire Thu, 11 Jun 2026 07:00:00 GMT
• ascendis pharma grants new employee warrants as part of updated equity incentive plan The Globe and Mail Thu, 11 Jun 2026 07:00:00 GMT
• ascendis boasts of long-term yorvipath data for hypoparathyroidism Seeking Alpha Thu, 11 Jun 2026 07:00:00 GMT
• daily brief health care: laurus labs, ascendis pharma, gsk , incyte corp, insmed inc, johnson & johnson, kardigan, logicmark, para... Smartkarma Thu, 11 Jun 2026 02:00:51 GMT
• [6-k] ascendis pharma a/s current report (foreign issuer) | asnd sec filing - form 6-k Stock Titan Wed, 10 Jun 2026 20:22:39 GMT
• ascendis pharma (asnd) issues 27,030 employee warrants at $213.23 exercise price Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• ascendis pharma grants 27,030 employee warrants at $213.23 per share Investing.com Wed, 10 Jun 2026 07:00:00 GMT
• Ascendis Pharma (ASND):10 Most Profitable Growth Stocks to Buy Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• Oppenheimer reiterates Ascendis Pharma stock rating amid ITC case Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• ascendis pharma a/s (asnd) stock analysis: unlocking a 40% upside potential with strong buy ratings DirectorsTalk Interviews Mon, 08 Jun 2026 09:21:46 GMT
• Assessing Ascendis Pharma (ASND) Valuation After Recent Share Price Weakness Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• Ascendis Pharma A/S to Present Latest Data on Endocrinology Rare Disease Programs at ENDO 2026 Quiver Quantitative Mon, 08 Jun 2026 07:00:00 GMT
• assessing ascendis pharma (nasdaqgs:asnd) valuation after recent share price weakness simplywall.st Mon, 08 Jun 2026 07:00:00 GMT
• ascendis pharma to present new data on rare endocrine disease treatments at endo 2026 conference. Pluang Mon, 08 Jun 2026 07:00:00 GMT
• ascendis to showcase advances in treatment of rare endocrine diseases at endo 2026 Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• while everyone was selling, i initiated a new position in this mid-cap biotech TheStreet Pro Sun, 07 Jun 2026 07:00:00 GMT
• td asset management inc has $49.90 million position in ascendis pharma a/s $asnd MarketBeat Sat, 06 Jun 2026 10:04:49 GMT
• Ascendis Pharma A/S Stock 12‑Month Price Target Raised to $295.6, Implies 40% Upside TradingView Sat, 06 Jun 2026 07:00:00 GMT
• asnd technical analysis | trend, signals & chart patterns | ascendis pharma a/s (nasdaq:asnd) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• ascendis pharma reports trial data on achondroplasia treatment Investing.com Thu, 04 Jun 2026 15:20:08 GMT
• ascendis pharma’s yuviwel gains orphan drug exclusivity in u.s. Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• insider buying: scott smith acquires additional shares of ascend GuruFocus Wed, 03 Jun 2026 00:57:05 GMT
• insider buying: scott smith acquires additional shares of ascendis pharma as (asnd) GuruFocus Tue, 02 Jun 2026 22:22:45 GMT
• alphacentric life sciences and healthcare fund's ascendis pharma as(asnd) holding history GuruFocus Tue, 02 Jun 2026 19:34:29 GMT
• (asnd) movement as an input in quant signal sets Stock Traders Daily Tue, 02 Jun 2026 18:44:02 GMT
• ascendis pharma (asnd) cfo acquires 100 ordinary shares in open-market buy Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• insider buying: jean bienaime acquires additional shares of asce GuruFocus Tue, 02 Jun 2026 01:52:30 GMT
• ascendis pharma a/s (asnd) stock analysis: a 33% upside potential in the biotech sector DirectorsTalk Interviews Mon, 01 Jun 2026 09:20:29 GMT
• ascendis pharma (asnd) director adds 500 shares in open-market buys Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• ascendis pharma (asnd) cfo makes open-market buy of 250 shares Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• ascendis pharma (nasdaq: asnd) cfo details shares, rsus and warrant stakes Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• what to know about this fund’s $50 million exit from ascendis pharma AOL.com Fri, 29 May 2026 22:26:16 GMT
• Ascendis Pharma slides 5.6% as investors digest recent run-up; no single headline catalyst apparent Quiver Quantitative Fri, 29 May 2026 07:00:00 GMT
• Ascendis Pharma: Rare Endocrine Compounder Entering Growth Phase (Initiating Buy) Seeking Alpha Thu, 28 May 2026 07:00:00 GMT
• ascendis pharma initiated with buy rating on strong growth, product launches, and upcoming milestones. Pluang Thu, 28 May 2026 07:00:00 GMT
• ascendis pharma (asnd) director bienaimé buys 400 ordinary shares Stock Titan Wed, 27 May 2026 07:00:00 GMT
• ascendis pharma a/s (asnd) stock analysis: riding the wave of impressive revenue growth and analyst optimism DirectorsTalk Interviews Mon, 25 May 2026 09:18:30 GMT
• ascendis pharma’s skytrofa gains fda approval for growth hormone deficiency MSN Sun, 24 May 2026 21:58:35 GMT
• asnd technical analysis | trend, signals & chart patterns | ascendis pharma a/s (nasdaq:asnd) ChartMill Fri, 22 May 2026 07:00:00 GMT
• asnd price today: ascendis pharma a/s stock price, quote & chart | mexc MEXC Fri, 22 May 2026 03:37:43 GMT
• citigroup initiates coverage of ascendis pharma a (asnd) with buy recommendation MSN Wed, 20 May 2026 07:26:22 GMT
• asnd initiates coverage by citigroup -- announces price target o GuruFocus Tue, 19 May 2026 21:41:08 GMT
• ascendis pharma a/s - ordinary share (nq: asnd The Chronicle-Journal Tue, 19 May 2026 20:00:02 GMT
• assessing ascendis pharma (asnd) valuation after recent soft trading and perceived discount simplywall.st Tue, 19 May 2026 07:00:00 GMT
• citigroup initiates coverage of ascendis pharma a (asnd) with buy recommendation MSN Tue, 19 May 2026 07:00:00 GMT
• which is a better investment, ascendis pharma a/s or biogen inc. stock? AAII Mon, 18 May 2026 12:42:42 GMT
• ASCENDIS PHARMA A/S (NASDAQ:ASND) Screens as a High-Growth Momentum Candidate ChartMill Mon, 18 May 2026 07:00:00 GMT
• morgan stanley maintains ascendis pharma a/s(asnd.us) with buy rating, cuts target price to $240.5 Moomoo Mon, 18 May 2026 07:00:00 GMT
• ascendis pharma a/s (asnd) stock analysis: impressive revenue growth and strong buy ratings signal a promising future DirectorsTalk Interviews Mon, 18 May 2026 07:00:00 GMT
• ascendis pharma a/s - ordinary share (nq: asnd The Chronicle-Journal Fri, 15 May 2026 20:00:01 GMT
• asnd maintained by evercore isi group -- price target raised to $329 GuruFocus Fri, 15 May 2026 18:37:08 GMT
• ascendis pharma price target raised to $329 from $324 at evercore isi TipRanks Fri, 15 May 2026 13:24:29 GMT
• we think shareholders should be aware of some factors beyond ascendis pharma's (nasdaq:asnd) profit 富途牛牛 Fri, 15 May 2026 11:32:50 GMT
• Ascendis Pharma (NASDAQ:ASND) Is Posting Healthy Earnings, But It Is Not All Good News Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• Statutory Earnings May Not Be The Best Way To Understand Ascendis Pharma's (NASDAQ:ASND) True Position simplywall.st Fri, 15 May 2026 07:00:00 GMT
• evercore maintains ascendis pharma a/s(asnd.us) with buy rating, raises target price to $329 Moomoo Fri, 15 May 2026 07:00:00 GMT
• asnd price today: ascendis pharma a/s stock price, quote & chart | mexc MEXC Fri, 15 May 2026 07:00:00 GMT
• ascendis pharma a/s - financialcontent - stock market FinancialContent Thu, 14 May 2026 15:58:58 GMT
• What to Know About This Fund’s $50 Million Exit From Ascendis Pharma The Motley Fool Thu, 14 May 2026 07:00:00 GMT
• capital international holds 2.01m shares of ascendis pharma (asnd) Stock Titan Thu, 14 May 2026 07:00:00 GMT
• ascendis pharma issues new employee warrants, keeps large pool available for future grants TipRanks Wed, 13 May 2026 20:36:35 GMT
Ascendis Pharma(NASDAQ:ASND) 
Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and Tran...
Website: http://www.ascendispharma.com
Founded: 2006
Full Time Employees: 330
Sector: Healthcare
Industry: Biotechnology